100 related articles for article (PubMed ID: 2477679)
21. [Expression of the epidermal growth factor receptor in esophageal cancer].
Mukaida H; Hirai T; Toi M; Nakamura T; Yamashita Y; Kawano K; Toge T; Niimoto M; Hattori T
Gan No Rinsho; 1989 Oct; 35(12):1399-406. PubMed ID: 2681876
[TBL] [Abstract][Full Text] [Related]
22. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.
Nozoe T; Korenaga D; Kabashima A; Ohga T; Saeki H; Sugimachi K
Clin Cancer Res; 2002 Mar; 8(3):817-22. PubMed ID: 11895914
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathological studies of DNA content in nuclei of cells isolated from patients with esophageal carcinoma (author's transl)].
Hiratsuka R
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):556-74. PubMed ID: 6276280
[No Abstract] [Full Text] [Related]
24. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Incarbone R; Bonavina L
Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
[No Abstract] [Full Text] [Related]
25. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
26. [Magnetic resonance imaging of esophageal carcinoma].
Sugimoto S; Harada J; Tada S
Rinsho Hoshasen; 1985 Oct; 30(10):1069-75. PubMed ID: 4094111
[No Abstract] [Full Text] [Related]
27. Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma.
Schaafsma HE; Van Der Velden LA; Manni JJ; Peters H; Link M; Rutter DJ; Ramaekers FC
J Pathol; 1993 May; 170(1):77-86. PubMed ID: 7686975
[TBL] [Abstract][Full Text] [Related]
28. [Characteristics of the lymph node metastases and influencing factors and their value in target region delineation in postoperative radiotherapy for thoracic esophageal carcinoma].
Li YM; Zhu SC; Liu ZK; Song CL; Wang YX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):391-5. PubMed ID: 20723441
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological significance of expressions of RECK and MMP-2 in esophageal squamous carcinoma].
Qi M; Li JS; Li Y
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):283-5. PubMed ID: 20510080
[TBL] [Abstract][Full Text] [Related]
30. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
31. [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma].
Hirata S; Yamazaki K; Yokoyama Y; Ueda M; Kubo Y; Samejima N
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):267-72. PubMed ID: 2747608
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and pathological analysis on esophageal carcinoma with a special reference to their intramural spreading characteristics (author's transl)].
Tanaka O
Nihon Kyobu Geka Gakkai Zasshi; 1979 Aug; 27(8):1132-44. PubMed ID: 501161
[No Abstract] [Full Text] [Related]
33. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
[TBL] [Abstract][Full Text] [Related]
34. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.
Ruol A; Stephens JK; Michelassi F; Segalin A; Chiarelli S; Peracchia A; Skinner DB; Little AG
J Surg Oncol; 1990 Jul; 44(3):142-5. PubMed ID: 2196399
[TBL] [Abstract][Full Text] [Related]
35. [Expression of nucleostemin mRNA and protein in the esophageal squamous cell carcinoma].
Zhang GY; Yin L; Li SL; Xing WY; Zhao QM; Le XP; Gao DL; Chen KS; Zhang YH; Zhang QX
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):125-8. PubMed ID: 18646696
[TBL] [Abstract][Full Text] [Related]
36. [Surgical treatment of primary adenocarcinoma of the esophagus].
Chen YH
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):371-3. PubMed ID: 2276332
[TBL] [Abstract][Full Text] [Related]
37. [Supplementary morphological criteria F anf G in the classification of esophageal cancer by the TNM system].
Kolosov AE; Dovgaliuk AZ; Stoliarov VI
Arkh Patol; 1993; 55(3):58-62. PubMed ID: 7944972
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma.
Hirashima K; Baba Y; Watanabe M; Karashima R; Sato N; Imamura Y; Hiyoshi Y; Nagai Y; Hayashi N; Iyama K; Baba H
Ann Surg Oncol; 2010 Sep; 17(9):2486-93. PubMed ID: 20339946
[TBL] [Abstract][Full Text] [Related]
39. [An immunohistochemical study on esophageal carcinomas with various kinds of antikeratin antibodies].
Mizutani N; Imamura M; Tobe T; Ito M
Nihon Geka Gakkai Zasshi; 1987 Apr; 88(4):422-31. PubMed ID: 2438549
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
